ROPINIROLE HYDROCHLORIDE
ROPINIROLE HYDROCHLORIDE
Approval overview ROPINIROLE HYDROCHLORIDE is listed in Drugs@FDA under application 217862 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ROPINIROLE HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - EQ 12MG BASE Sponsor ELITE LABS INC Submission history Latest submission status date: 2025-11-10 00:00:00.
Structured Monograph
Clinical summary
Approval overview ROPINIROLE HYDROCHLORIDE is listed in Drugs@FDA under application 217862 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ROPINIROLE HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - EQ 12MG BASE Sponsor ELITE LABS INC Submission history Latest submission status date: 2025-11-10 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.